Progressive Retinal Atrophy and Breeding Decisions: A Practical Guide

Progressive Retinal Atrophy is one of the most feared hereditary conditions in purebred dogs — and for good reason. It causes progressive, irreversible blindness with no cure. The disease can be passed invisibly through carriers for generations before an affected dog appears. When it does appear, the results are devastating for the dog and heartbreaking for its family.

For breeders, PRA is manageable. Not easily managed, but manageable. The combination of annual clinical eye certification and DNA testing for known mutations gives breeders the tools to reduce PRA prevalence systematically. What this requires is commitment, patience, and a willingness to make difficult decisions when a valued animal turns out to be a carrier or affected.

Understanding PRA Biology

PRA refers to a group of inherited retinal diseases that cause progressive degeneration of the rod and cone photoreceptors. Different mutations cause different forms of PRA, with variable age of onset and rate of progression. Most forms follow autosomal recessive inheritance, meaning a dog must inherit two copies of the defective gene — one from each parent — to be clinically affected. Dogs with one copy are carriers and show no clinical signs but can pass the mutation to offspring.

The practical implication of recessive inheritance is that two carrier parents can produce affected offspring even though neither parent is affected. If both parents are carriers, statistically 25% of offspring will be affected, 50% will be carriers, and 25% will be clear. This is how PRA can spread through a breeding population for decades before the problem becomes apparent.

The clinical presentation typically begins with night blindness, as rod photoreceptors degenerate first. Owners notice their dog becomes hesitant in dim light, bumps into things in low-light conditions, or seems disoriented at night. As the disease progresses, daytime vision deteriorates and most affected dogs are completely blind within one to three years of the first clinical signs.

Clinical Certification and PRA Detection

Annual OFA eye certification by an ACVO diplomate can detect PRA changes before obvious blindness occurs. The retinal changes associated with PRA — vascular attenuation, tapetal hyperreflectivity, and eventual retinal degeneration — are visible on indirect ophthalmoscopic examination. Early detection allows breeders to remove affected animals from breeding programs before they produce additional affected offspring.

The limitation of clinical detection is that it cannot identify carriers. A carrier dog's retina looks completely normal. Annual certification will be clean year after year until age reveals no hidden problems or, if affected, begins showing changes. This is why clinical certification alone is not sufficient for PRA management in breeds where the condition is prevalent.

The retesting schedule guide addresses why annual exams are important specifically for late-onset conditions like PRA — early exams in young dogs do not rule out future development of the condition.

DNA Testing for PRA

The most significant advance in PRA management has been the development of breed-specific DNA tests. These tests identify the specific mutations associated with PRA in particular breeds and can classify individual dogs as Clear, Carrier, or Affected from a simple cheek swab or blood sample.

Available PRA DNA tests include prcd-PRA (affects Labrador Retrievers, Poodles, Cocker Spaniels, Portuguese Water Dogs, and many others), cord1-PRA (Miniature Dachshunds), rcd1-PRA (Irish Setters), rcd3-PRA (Cardigan Welsh Corgis), crd4/cord1 (Standard Poodles and several other breeds), and several others. The specifics of which test applies to which breed can be obtained from laboratories such as Embark, Optigen, or the Animal Health Trust.

DNA testing provides information that clinical exams cannot — specifically, carrier status. A dog who tests as Carrier can be used in a breeding program if bred to a Clear partner, producing no affected offspring while allowing the carrier's other valuable traits to contribute to the gene pool. This is particularly important in breeds where PRA carriers are common, because eliminating all carriers at once could create damaging genetic bottlenecks. The complete guide on DNA vs clinical exams covers this balance in depth.

The Clear by Parentage Shortcut

Some breeders use a provision called Clear by Parentage for PRA DNA testing. If both parents of a dog are DNA-tested Clear for a particular PRA mutation, that dog statistically cannot be Affected or Carrier for that specific mutation. This is mathematically sound and can save testing costs for dogs where the parentage is reliably verified through DNA parentage testing.

However, Clear by Parentage only works if the specific mutation tested in the parents is the correct test for the breed, parentage is DNA-verified (not just assumed from pedigree records), no new mutations have occurred, and no other PRA mutations affect the breed that were not tested. For well-characterized breeds with only one known PRA mutation and rigorous parentage verification, Clear by Parentage is a valid and practical approach. For breeds with multiple PRA forms or where parentage is uncertain, direct testing is safer.

Breeding Strategies with PRA-Affected Lines

If DNA testing reveals a dog in your breeding program is a Carrier, this is not automatically a crisis. Carriers can be bred to Clear dogs. The resulting offspring can be tested, and Clear offspring can be retained while Carriers are placed as pets or used with Clear partners going forward. Over two to three generations, this systematic approach can dramatically reduce or eliminate PRA from a line.

The key is commitment and transparency. Breeders who hide carrier status from partners are actively harming the breed. If you know your dog is a Carrier and you breed to another known Carrier without disclosing this, you are making a choice that will produce affected puppies. The community norm around transparency in sharing PRA test results has improved substantially in recent decades, and responsible breeders share test results freely.

What Annual Certification Adds Beyond DNA Testing

If you have DNA tested your dog and they are Clear, do annual eye exams still matter? Yes, for several reasons. DNA tests only cover known mutations. New mutations can arise that no current test detects. Clinical examination can detect retinal changes that may represent novel forms of PRA not yet characterized. Annual certification builds a long-term record of retinal health that may become important if your lines are evaluated for novel conditions in the future.

Additionally, annual certification catches other eye conditions that are not related to PRA at all — cataracts, PPM, distichiasis, and others that require management regardless of PRA status. The annual exam is part of a comprehensive eye health approach, not just a PRA screening tool.

Communicating PRA Status to Buyers

Puppy buyers of breeds affected by PRA should receive full documentation of both parents' PRA DNA test results and current OFA eye certification. If you are selling a puppy from a Clear-to-Carrier breeding, disclose the carrier parent's status clearly and explain what it means for the puppy — that the puppy may be Clear or Carrier (not Affected) and that testing is recommended if they plan to breed.

The puppy buyer records guide provides a framework for what documentation to include. For PRA specifically, include the specific mutation tested, the laboratory, and the result for both parents.

Multi-Generational PRA Management

Reducing PRA prevalence in a breed is a long-term project that requires consistent effort across multiple breeding generations. Individual decisions compound over time. Breeders who test consistently, share results transparently, and make breeding decisions based on health data rather than solely on conformation contribute to breed improvement in ways that cannot be achieved in a single generation.

The broader framework for thinking about multi-generational eye health management is in the multi-generational eye health guide. PRA is one of several conditions that requires this long view, and the principles that apply to PRA management apply to other hereditary conditions as well.